Introduction. Women with a history of placental abruption have an increased later morbidity, but not much is known of the later mortality. Material and methods. Data on women with placental abruption (index cohort) between 1969 and 2005 (n = 7805) were collected from the Finnish Hospital Discharge Register and the Finnish Medical Birth Register. A matched reference cohort consisted of women without placental abruption (n = 23 523). The causes of death were retrieved from the Cause-of-Death Register. Cause-specific mortality was compared by hazard ratios (HR). Standardized mortality ratios were calculated to compare both cohorts with the general female population. The main outcome measure was subsequent mortality. Results. By the end of 2013 there were 395 deaths in the index cohort and 863 deaths in the reference cohort. The overall mortality was increased in the index cohort compared with the reference cohort [HR 1.39, 95% confidence interval (CI) 1.24-1.57]. The index cohort had an increased risk of death from respiratory tract malignancies (HR 1.72, 95% CI 1.05-2.82), alcohol-related causes (HR 1.84, 95% CI 1.25-2.72), and external causes (HR 1.63, 95% CI 1.19-2.22), especially suicide (HR 1.71, 95% CI 1.07-2.74). The mortality from cardiovascular diseases did not differ. The standardized mortality ratio was increased in the index cohort compared with the general Finnish female population (HR 1.13, 95% CI 1.02-1.24), especially for respiratory tract malignancies (HR 1.79, 95% CI 1.16-2.64). The index cohort women tended to die younger than referent women (p < 0.001). Conclusions. Overall mortality among women with a history of placental abruption is increased. These women tend to die younger than referent women do.
hemorrhage, emergency hysterectomy, disseminated intravascular coagulation, renal failure, and even maternal death (1, 2) . At least 50 risk factors for placental abruption, related to maternal behavior and pregnancy-associated risks, have been identified, the most important being smoking, preeclampsia, and a history of placental abruption (3) . The etiology of placental abruption is not fully understood but it appears that the syndromes of ischemic placental diseases include the related conditions of placental abruption, preeclampsia, and intrauterine growth restriction (4) (5) (6) . These so-called placental syndromes share similar histopathological features, including defective trophoblastic invasion of the spiral arteries and endothelial dysfunction leading to uteroplacental underperfusion (7) .
A history of preeclampsia is associated with increased risk for cardiovascular disease (CVD) in later life (8) (9) (10) (11) and increased overall mortality (8, 9) . The risk for premature CVD may also be increased in women with a history of placental abruption (7, 12) . However, data on longterm CVD mortality in these women are conflicting (13) (14) (15) and not much is known about their overall mortality (14) . Furthermore, little is known about relations between placental abruption and later life cancer morbidity and mortality. In one report, the subsequent breast cancer risk was nearly doubled (16) . However, the overall cancer mortality has not been studied.
Our aim was to examine more thoroughly the overall and cause-specific mortality among women with a history of placental abruption with a specific focus on cancer and CVD mortality. For this, we used the nationwide and comprehensive healthcare registers of Finland.
Material and methods
We conducted a retrospective population-based cohort study using linked data from population-based birth and cause-of-death registers from Finland. The data on the cohorts were collected from the Medical Birth Register (MBR) and the Hospital Discharge Register (HDR), maintained by the National Institute for Health and Welfare. All patients with the diagnosis of placental abruption who delivered between 1969 and 2005 were identified (index cohort). With the HDR, we used the International Classification of Diseases (ICD) codes ICD-8 632.1, 632.4, and 632.2 for the years 1969-1986, ICD-9 codes 641.20, 641.21, and 641.23 for 1987-1995, and ICD-10 codes O45.0, O45.8, and O45.9 for the years after 1996. A check-box on placental abruption (yes/no) was used with the MBR (October 1990 (October -2005 . A reference cohort originated from the same registers (HDR, MBR) and consisted of three women without placental abruption for each abruption, matched by maternal age, parity, multiplicity, year of birth, and hospital district area. If all controls were not found, the age criteria were loosed by +/À one year to obtain three controls for each case.
This study was part of a larger study protocol (1, (17) (18) (19) . There were 7805 women with at least one placental abruption; some of these women had a recurrent abruption. Altogether, 23 523 women made up the reference cohort. Women with recurrent abruption had controls chosen for each of their abruption episodes.
Baseline data on interventions that the mothers received during pregnancy and delivery were collected from the MBR (available since 1987). All live births and stillbirths with either gestational age of at least 22 completed weeks (≥155 days) or birthweight ≥500 g are registered in the MBR. The data are compiled at the time of birth using the mother's maternity records. Less than 0.1% of all births are missing from the MBR. The register data have been validated and correspond well with data available from hospital records (20, 21) .
In the HDR, data are collected on all inpatient episodes in all hospitals (since 1967), all outpatient surgical procedures in public hospitals (since 1994), and all outpatient visits in public hospitals (since 1998). The register contains information on admissions, discharge dates, and diagnoses.
To identify all deaths recorded up to the end of 2013, the individuals of the index and reference cohorts were linked to the Cause-of-Death register (maintained by Statistics Finland) by their unique personal identity number. Causes of death were obtained from death certificates. The determination of the cause of death is based on medical or forensic evidence required for the death certificate. Forensic cause of death assignment may be necessary if death is not the result of an illness, i.e. if it was accidental or violent, or caused by a treatment procedure or an occupational disease (22 We also compared mortality in the index and reference cohorts with mortality in the general Finnish female population. This comparison was performed for all-cause mortality and the 53 specific cause-of-death categories included in the Statistics Finland data (22) . The followup periods commenced at the relevant delivery and ended at death or at study termination on 31 December 2013.
Statistical analyses
Crude death rates/100 000 person-years were calculated for both cohorts. Age-adjusted hazard ratios (HR) with 95% confidence intervals (CI) were calculated for index and reference cohorts by the Cox hazard regression method. The expected number of deaths was calculated by multiplying the age-and calendar-period-specific numbers of person-years by the respective mortality rates in the general Finnish female population obtained from Statistics Finland. Standardized mortality ratios (SMR) were calculated as the ratio of observed to expected number of deaths, and the 95% CI were defined assuming Poisson distribution of the observed number of deaths.
HRs were calculated by age at delivery and by five-year periods since delivery. A p-value <0.05 was considered significant. The HR analyses were performed by IBM SPSS STATISTICS version 23 (IBM Corp., Armonk, NY, USA).
The study was approved by the National Institute for Health and Welfare (the register keeper), which also authorized the use of health register data in scientific research (permission 1202/5.05.00/2013), as required by national data protection legislation. Statistics Finland authorized the use of cause-of-death register data (permission TK-53-1035-13).
Ethical approval
The protocol for this study was approved by the Ethical Committee of Helsinki University Hospital (permission number 334/13/03/03/2013; date of approval 19 December 2013). As this study used routinely collected anonymized electronic health records, no formal patient consent was required.
Results
There were 2 275 869 deliveries during the study period. A total of 395 deaths in the index cohort and 863 deaths in the reference cohort had been recorded by the end of 2013. The median follow-up time was 24.9 years (range 0-45 years). The baseline characteristics of the study population from 1987 to 2005 have been reported previously (17) . Overall, 22% of the women with placental abruption and 15% of the reference women smoked during the pregnancy (p < 0.001) (17) . Baseline data including smoking during pregnancy, marital status, and socioeconomic status were not available for women who had delivered between 1969 and 1986. The modified classification of the national time series for 53 cause-of-death categories for the index and reference cohorts is shown in Supporting Information Appendix S1.
When comparing the index and reference cohorts, an increased overall mortality was observed among women with a history of placental abruption (HR 1.39, 95% CI 1.24-1.57) ( Table 1 ). The mortality from all malignant neoplasms (calculated from 18 different subgroups) was not increased (HR 1.09, 95% CI 0.90-1.31). In the subgroup analysis, only the mortality from malignancies of larynx, trachea, bronchus, and lung (pulmonary tissue) was increased (HR 1.72, 95% CI 1.05-2.82). No significant differences in mortality were observed in the other cancer subgroups (Table 1 ). In the category of external causes, suicides were more common in the index than in the reference cohort (HR 1.71, 95% CI 1.07-2.74). Mortality due to alcohol-related causes was also increased (HR 1.84, 95% CI 1.25-2.72) ( Table 1) .
Smoking increased the risk for malignancies of larynx, trachea, bronchus, and lung (HR 20.0, 95% CI 3.98-100, data not shown). We were unable to analyze the role of maternal smoking during pregnancy in other cause-ofdeath categories due to the small numbers. Socioeconomic status was not associated with cause-specific mortality; however, the number of deaths was relatively small.
For ischemic and cerebrovascular diseases there were no differences in mortality between the cohorts (Table 1) . Of cerebrovascular diseases, ischemic cerebrovascular diseases were analyzed as a separate entity, but the mortality difference between the cohorts was insignificant (HR 2.42, 95% CI 0.81-7.24, data not shown).
Mortality in other diseases and medical conditions could be divided into several subgroups: infectious and parasitic diseases; endocrine, nutritional, and metabolic diseases; dementia, Alzheimer's disease; other diseases of the nervous system and sense organs; diseases of the respiratory, digestive, and genitourinary system; congenital malformations and chromosomal abnormalities; maternal deaths; other diseases, symptoms, and signs not classified elsewhere (Appendix S1). There were five maternal deaths in the index cohort and three in the reference cohort. Only three of the five deaths in the index cohort were related to the index pregnancy with placental abruption.
SMR analysis was used to compare the index cohort and the reference cohort with the general Finnish female population. This revealed an increased overall mortality in the index cohort (SMR 1.13, 95% CI 1.02-1.24; Table 1 ) and a decreased overall mortality in the reference cohort (SMR 0.81, 95% CI 0.76-0.86). The women in the index cohort had an excess mortality risk in the subgroup of malignancies of larynx, trachea, bronchus, and lung (SMR 1.79, 95% CI 1.16-2.64). The mortality in the reference cohort was especially decreased for alcoholrelated causes (SMR 0.70, 95% CI 0.54-0.88), and external causes (SMR 0.63, 95% CI 0.52-0.75), particularly suicides (SMR 0.58, 95% CI 0.42-0.76).
All-cause mortality by maternal age and by five-year periods after the index delivery are shown in Table 2 . The risk of excess death decreased with increasing age at delivery (p < 0.001). The greatest relative difference in mortality was observed 15-19 years after the delivery (HR 1.76, 95% CI 1.30-2.38). Figure 1 shows that the cumulative hazard of death in the index cohort was higher than in the reference cohort (p < 0.001), suggesting that women with a history of placental abruption tend to die younger.
Discussion
In this population-based cohort study we showed that overall mortality among women with a history of placental abruption was increased. These women also tended to die younger compared with the reference cohort. The increase in the risk might be due to the greater number of smokers in the index cohort. The women in the index cohort had an increased risk of death from malignancies of larynx, trachea, bronchus, and lung, and from alcoholrelated causes and other external causes, such as suicides. Surprisingly, there was no increase in deaths from CVD.
Our study has several strengths and limitations. The study was based on national data obtained from validated and comprehensive health registers. The index and reference cohorts were large. However, the actual number of deaths in both cohorts was relatively small, which limits the conclusions that can be drawn. Despite this, our novel finding was that women with a history of placental abruption had an increased risk of dying of respiratory tract malignancies. This is likely to be an association For five women in the index cohort and five women in the reference cohort the cause of death was unknown. These women died abroad. There were 87 deaths in the index cohort and 121 deaths in the reference cohort due to other diseases and medical conditions, such as certain infectious and parasitic diseases; endocrine, nutritional and metabolic diseases; dementia, Alzheimer's disease; other diseases of the nervous system and sense organs; diseases of the respiratory, digestive and genitourinary system; congenital malformations and chromosomal abnormalities; maternal deaths; other diseases, symptoms and signs, not classified elsewhere. which is indirect, i.e. women who smoke are more likely to have both an abruption and respiratory cancers in later life. Unfortunately, the baseline characteristics were unavailable for women who had delivered or died before 1987. However, the mortality from respiratory tract malignancies was clearly increased among women who had delivered after 1987 and who smoked. Due to the limited number of deaths, the role of smoking and socioeconomic status as such on other cause-of-death categories could not be reliably analyzed. Other limitations of the study were also evident. Changes in the MBR and the HDR took place during the study period. Increased mortality of malignancies of larynx, trachea, bronchus, and lung as a whole was observed in relation to both the reference cohort and general Finnish female population. Smoking has been shown to be one of the most important and well-known risk factors for placental abruption (3, 18, 19, 24, 25) . It is also a major risk factor for many cancers in general, especially lung cancer (26) . We have previously demonstrated that smoking women with subsequent placental abruption have higher median levels of serum cotinine compared with smoking control women. This suggests that women with placental abruption smoke more heavily during pregnancy than control women do (27) . The underlying mechanisms of smoking being associated with placental abruption are largely unknown. We emphasize that although the risk increase for respiratory cancers was 40%, the number of cases was only 25. One additional limitation was that we had no data of smoking habits after the delivery or passive-smoking exposure. We acknowledge that these findings have no major clinical implications since counseling on smoking cessation is important for all women and not only after placental abruption.
No studies have focused purely on placental abruption and subsequent cancer mortality. In our study, all cancers were analyzed. The respiratory tract, gynecological organs, and breast cancers were of special interest based on the previously published data. In a US study (16) the risk of breast cancer was nearly doubled. In a Swedish-Norwegian study (14) focusing mainly on long-term CVD mortality, cancer-related deaths were not increased among women with a history of recurrent placental abruption. We found no evidence of increased mortality from breast cancer, gynecological cancer, or any other cancers apart those from the respiratory tract.
Alcohol use during pregnancy has also been associated with increased risk of placental abruption (25) . We observed an almost twofold mortality from alcoholrelated causes in the index cohort. Drug-or alcoholrelated deaths were also increased among women with history of recurrent placental abruption in another study (14) . We had no data of alcohol use during or after the index pregnancy. However, the rate of accidental or violent deaths, especially suicides, was similar to that reported for the general Finnish female population, although somewhat higher than in the reference cohort.
Three previous studies have examined placental abruption and subsequent maternal CVD mortality (13) (14) (15) . Our study was in line with a large register-based study from Denmark in which no increased CVD mortality was found (15) . However, CVD mortality was increased in the two other studies (13, 14) . The overall mortality of patients with a history of placental abruption has been assessed in only one previous study (13) in which the results were similar to ours. The reasons for inconsistency between the studies may be differences in population characteristics, study designs including case definitions, and length of follow up. Studies suggest an increased risk of CVD morbidity among women with a history of placental abruption (7, 12) . However, CVD mortality in women was decreasing during the study period both in Finland and elsewhere (28) . Still, we find it surprising that the CVD mortality between the cohorts was similar but that mortality from respiratory tract malignancies was increased in the index cohort. Although the point estimate of the HR was 2.42, the 95% CI crossed one, and this was not significant. The study may have been underpowered for cardiovascular mortality.
The highest relative excess mortality in the index cohort was 15-19 years after delivery. It should be considered that the general mortality in the reference population increases with age and hence the absolute excess risk may be highest in the older age categories, although the relative excess risk is higher in the younger age categories.
Comparing the index cohort and the reference cohort with the general Finnish female population by the SMR analysis was an additional strength in the study. When compared with the general population, mortality was decreased in the reference cohort in most cause-of-death categories. This could be explained by the healthy-pregnant-women effect according to which the risk of a medical-condition-related death within the first year after the delivery is lower than the risk among non-pregnant women in the same age group (29) . Our study showed that this effect may last several years. In one study, parous women had lower all-cause mortality compared with nulliparous women in the age group "more than 60 years" (30) . In many studies, the only comparison of mortality among women with placental abruption has been done with other pregnant women. As we demonstrate, the mortality rates in such reference groups differ from those in the general population, and the relative risk estimates may thus appear higher.
Behavioral risk factors such as smoking, alcohol and substance abuse may have an impact on overall mortality among women with history of placental abruption. This should be kept in mind while counseling such women after the delivery.
